PT Medco Energi Internasional (MEDC) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
1H 2024 revenue reached US$1.17 billion, up 4.4% year-over-year, with net income of US$201 million, a 68.9% increase, driven by AMMN contributions and asset divestments.
EBITDA for 1H 2024 was US$650 million, up 2.5% year-over-year.
Completed Vietnam and Libya divestments, generating US$120 million in cash proceeds.
Acquired 20% interest in Oman Block 60, recognized as APAC "Deal of the Year" and booked a US$36.2 million bargain purchase gain.
Paid US$44.9 million in cash dividends from 2023 profits in June 2024.
Financial highlights
1H 2024 revenue was US$1,165 million, up 4% year-over-year.
Net profit attributable to owners was US$201 million, up from US$119 million year-over-year.
EBITDA reached US$650 million, up from US$634 million year-over-year.
Gross profit for 1H 2024 was US$451 million.
Operating cash flow was US$593.5 million, up from US$179 million year-over-year.
Outlook and guidance
2024 oil & gas production guidance set at 145–150 mboepd; power sales guidance at 4,100 GWh.
Full-year capex guidance is US$430 million; oil & gas cash cost expected below US$10/boe.
Net debt to EBITDA targeted below 2.5x for 2024.
Focus on new reserves, selective portfolio management, and continued dividend and debt repayments.
Progressing major renewable projects: Ijen Geothermal (Q1 2025 commercial ops) and Bulan Island Solar PV.
Latest events from PT Medco Energi Internasional
- EBITDA dropped 4% to $623M in 1H 2025; major Corridor PSC stake acquired.MEDC
Q2 20258 Jan 2026 - Stable EBITDA and higher dividends offset lower net income amid major asset acquisitions.MEDC
Q3 20258 Jan 2026 - Diversified energy operations, robust growth, and ESG leadership drive superior shareholder returns.MEDC
CMD 2024 Presentation4 Jul 2025 - Q1 EBITDA rose to $332mn, with strong operations, liquidity, and key project milestones achieved.MEDC
Q1 202517 Jun 2025 - Net income and revenue rose in 9M 2024, supported by asset optimization and strong cash flow.MEDC
Q3 202413 Jun 2025 - Record 2024 results with net income up 11% and strong growth across all segments.MEDC
Q4 20245 Jun 2025